MELANIE ANN LAUB

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health GILBERT, AZ NPI 1679166805

General Payments — all program years on this page

$3,861.79

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 69
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $878.65 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $851.3819
Education $27.271

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $754.009
2022 $1,291.6920
2023 $937.4520
2024 $878.6520

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077913613 Janssen Pharmaceuticals, Inc $124.54 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077913647 Janssen Pharmaceuticals, Inc $33.86 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1077913815 Janssen Pharmaceuticals, Inc $127.57 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101252854 E.R. Squibb & Sons, L.L.C. $27.27 11/15/2024 Education Undisputed 01/23/2026 View at CMS
1101252880 E.R. Squibb & Sons, L.L.C. $121.84 11/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119119173 Otsuka America Pharmaceutical, Inc. $14.67 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119119175 Otsuka America Pharmaceutical, Inc. $28.77 03/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119119177 Otsuka America Pharmaceutical, Inc. $19.32 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120539053 Alkermes, Inc. $5.77 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120539055 Alkermes, Inc. $20.26 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120539057 Alkermes, Inc. $107.27 04/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120539059 Alkermes, Inc. $4.06 06/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120539061 Alkermes, Inc. $12.53 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120539063 Alkermes, Inc. $23.42 08/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120539065 Alkermes, Inc. $17.85 10/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120539067 Alkermes, Inc. $18.20 12/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133953564 Vanda Pharmaceuticals Inc. $13.45 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133953566 Vanda Pharmaceuticals Inc. $125.00 03/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151672808 Teva Pharmaceuticals USA, Inc. $16.27 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151672989 Teva Pharmaceuticals USA, Inc. $16.73 10/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.